CN1558756A - 用于治疗泌尿疾病的药物组合物 - Google Patents

用于治疗泌尿疾病的药物组合物 Download PDF

Info

Publication number
CN1558756A
CN1558756A CNA028188764A CN02818876A CN1558756A CN 1558756 A CN1558756 A CN 1558756A CN A028188764 A CNA028188764 A CN A028188764A CN 02818876 A CN02818876 A CN 02818876A CN 1558756 A CN1558756 A CN 1558756A
Authority
CN
China
Prior art keywords
compositions
chemical compound
disease
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028188764A
Other languages
English (en)
Chinese (zh)
Inventor
Sp
S·P·阿纳里克
P－O·安德松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/965,556 external-priority patent/US20030060513A1/en
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of CN1558756A publication Critical patent/CN1558756A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA028188764A 2001-09-27 2002-09-26 用于治疗泌尿疾病的药物组合物 Pending CN1558756A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/965,556 US20030060513A1 (en) 2001-09-27 2001-09-27 Pharmaceutical composition
US09/965,556 2001-09-27
SE01038587 2001-11-20
SE0103858A SE0103858D0 (sv) 2001-09-27 2001-11-20 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
CN1558756A true CN1558756A (zh) 2004-12-29

Family

ID=26655594

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028188764A Pending CN1558756A (zh) 2001-09-27 2002-09-26 用于治疗泌尿疾病的药物组合物

Country Status (9)

Country Link
EP (1) EP1438035A2 (xx)
JP (1) JP2005503424A (xx)
KR (1) KR20040039436A (xx)
CN (1) CN1558756A (xx)
BR (1) BR0212824A (xx)
CA (1) CA2461731A1 (xx)
IL (1) IL160852A0 (xx)
MX (1) MXPA04002496A (xx)
WO (1) WO2003026564A2 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
FR2843303B1 (fr) * 2002-08-07 2006-01-21 R & D Pharma Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
CN100382794C (zh) * 2004-08-30 2008-04-23 鲁南制药集团股份有限公司 酒石酸托特罗定的分散片剂型
WO2009151613A1 (en) * 2008-06-13 2009-12-17 Concert Pharmaceuticals, Inc. Oxybutynin derivatives
EP2363397A4 (en) * 2008-11-07 2012-07-11 Dainippon Sumitomo Pharma Co NEW THERAPEUTIC AGENT USEFUL FOR SYMPTOM OF LOWER URINARY TRACT
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
JP2022529781A (ja) 2019-04-17 2022-06-24 コンパス パスファインダー リミテッド サイロシビンによるうつ病及び他の様々な障害の治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417135D0 (en) * 1994-08-23 1994-10-12 Medinnova S F Method
IT1282705B1 (it) * 1996-02-28 1998-03-31 Recordati Chem Pharm Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
WO1999021563A1 (en) * 1997-10-28 1999-05-06 Merck & Co., Inc. Prevention of precipitated acute urinary retention
WO2001021167A1 (en) * 1999-09-22 2001-03-29 Merck & Co., Inc. Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein
IT1314192B1 (it) * 1999-10-18 2002-12-06 Recordati Chem Pharm Derivati benzopiranici

Also Published As

Publication number Publication date
WO2003026564A2 (en) 2003-04-03
CA2461731A1 (en) 2003-04-03
MXPA04002496A (es) 2004-05-31
EP1438035A2 (en) 2004-07-21
JP2005503424A (ja) 2005-02-03
WO2003026564A9 (en) 2004-06-17
BR0212824A (pt) 2004-10-13
WO2003026564A3 (en) 2003-12-11
IL160852A0 (en) 2004-08-31
KR20040039436A (ko) 2004-05-10

Similar Documents

Publication Publication Date Title
US10004731B2 (en) Flibanserin for the treatment of urinary incontinence and related diseases
CN1717230A (zh) 包含β－3－肾上腺素能受体激动剂以及血清素和/或去甲肾上腺素再摄取抑制剂的药物组合物
US20090176698A1 (en) Benzimidazolone Derivatives for the Treatment of Urinary Incontinence
US20020010216A1 (en) New drug combinations
CN1889938A (zh) 用于预防或减少自杀性和治疗与自杀性相关的重性抑郁症的美金刚
CN1658859A (zh) 治疗膀胱过度活动的药物
CN1558756A (zh) 用于治疗泌尿疾病的药物组合物
CN1543344A (zh) 治疗尿失禁的芳基(或杂芳基)氮杂茂甲醇衍生物
MXPA06004625A (es) Composicion famaceutica que contiene un agonista de un adrenoceptor beta-3 y un antagonista alfa y/o un inhibidor de la 5-alfa-reductasa.
ZA200402362B (en) Pharmaceutical compositions for the treatment of urinary disorders.
CN1622803A (zh) 1－苯基－3－二甲基氨基丙烷化合物用于治疗尿失禁的用途
RU2280444C2 (ru) Применение 6-диметиламинометил-1-фенилциклогексановых соединений для терапии недержания мочи
CN1518444A (zh) 取代的6-二甲基氨基甲基-1-苯基环己烷化合物治疗尿失禁的用途
CN1291715C (zh) 含有依匹斯汀及假麻黄碱的新药物组合物
AU2002341479A1 (en) Pharmaceutical compositions for the treatment of urinary disorders
CN1874791A (zh) 含有β－3－肾上腺素受体－激动剂和α拮抗剂和/或5－α还原酶－抑制剂的药物组合物
CN1694692A (zh) 改善下腹和/或会阴疼痛的治疗剂
JP2004507447A (ja) 腹圧性尿失禁の治療のためのα１Ｂおよびα１Ｄ拮抗作用を有するα１Ａアドレナリン受容体アゴニストの使用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1069310

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1069310

Country of ref document: HK